Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 27, 2019	Sep. 28, 2018
Current assets:
Cash and cash equivalents	$ 797,210	$ 918,063
Restricted cash	8,383	7,187
Short-term investments	119,146	178,138
Accounts receivable, net of allowance for doubtful accounts of $9,775 and $5,258	189,115	166,133
Contract with Customer, Asset, Net	195,651	165,959
Inventories	32,331	26,206
Prepaid expenses and other current assets	39,704	34,890
Total current assets	1,381,540	1,496,576
Long-term investments	179,587	187,782
Property, plant and equipment, net	537,432	514,182
Intangible assets, net	180,891	184,019
Goodwill	334,829	327,982
Deferred taxes	114,075	74,766
Other non-current assets	93,395	80,080
Total assets	2,821,749	2,865,387
Current liabilities:
Accounts payable	15,212	21,922
Accrued liabilities	268,144	243,128
Income taxes payable	3,506	2,680
Contract liabilities	19,991	17,468
Total current liabilities	306,853	285,198
Non-current contract liabilities	24,404	25,887
Other non-current liabilities	177,462	183,799
Total liabilities	508,719	494,884
Stockholders' equity:
Additional paid-in capital	0	66,127
Retained earnings	2,327,877	2,313,539
Accumulated other comprehensive income	(20,625)	(15,832)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,307,351	2,363,936
Controlling interest	5,679	6,567
Total stockholders’ equity	2,313,030	2,370,503
Total liabilities and stockholders’ equity	2,821,749	2,865,387
Class A Common Stock [Member]
Stockholders' equity:
Common stock	58	61
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 41	$ 41